1. Choi CW, Kim BR, Seo E, Youn SW. The objective Psoriasis Area and Severity Index: a randomized controlled pilot study comparing the effectiveness of ciclosporin and methotrexate. Br J Dermatol. 2017; 177:1740–1741.
Article
2. Singh S, Pandey SS. Evaluation of efficacy of therapy for psoriasis : methodological issues. Indian J Dermatol Venereol Leprol. 1997; 63:211.
3. Armstrong AW, Parsi K, Schupp CW, Mease PJ, Duffin KC. Standardizing training for psoriasis measures: effectiveness of an online training video on Psoriasis Area and Severity Index assessment by physician and patient raters. JAMA Dermatol. 2013; 149:577–582.
4. Faria JR, Aarão AR, Jimenez LM, Silva OH, Avelleira JC. Inter-rater concordance study of the PASI (Psoriasis Area and Severity Index). An Bras Dermatol. 2010; 85:625–629.
5. Choi CW, Kim BR, Park JS, Youn SW. Both educational lectures and reference photographs are necessary to improve the accuracy and reliability of Psoriasis Area and Severity Index (PASI) assessment: results from Korean nation-wide PASI educational workshop. Ann Dermatol. 2018; 30:284–289.
Article